Cargando…

Molecular and clinical assessment of maturity-onset diabetes of the young revealed low mutational rate in Moroccan families

BACKGROUND: Maturity-onset diabetes of the young (MODY) is a monogenic form of diabetes characterized by autosomal dominant inheritance. To offer an adequate patient management and therapeutic treatment for MODY patients, in addition to an early efficient diagnosis of their asymptomatic relatives, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Trhanint, Said, Bouguenouch, Laila, Abourazzak, Sana, El Ouahabi, Hanan, Latrech, Hanane, Benyakhlef, Salma, Bennani, Bahia, El Bouchikhi, Ihssane, Moufid, Fatima Zahra, Ouldim, Karim, El Ghadraoui, Lahsen, Maazouzi, Nadia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: King Faisal Specialist Hospital and Research Centre 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152556/
https://www.ncbi.nlm.nih.gov/pubmed/35663783
http://dx.doi.org/10.1016/j.ijpam.2021.03.006
Descripción
Sumario:BACKGROUND: Maturity-onset diabetes of the young (MODY) is a monogenic form of diabetes characterized by autosomal dominant inheritance. To offer an adequate patient management and therapeutic treatment for MODY patients, in addition to an early efficient diagnosis of their asymptomatic relatives, it is crucial to set an accurate molecular diagnosis. Hence, our aim was to determine the frequency of HNF1A and GCK genes among Moroccan-suspected MODY patients. METHODS: Twenty suspected MODY patients were screened for HNF1A and GCK mutations using Sanger sequencing and MLPA methods. Segregation analysis of identified mutations was performed among family members. The pathogenic nature of missense variants was predicted using bioinformatic tools. RESULTS: A total of two mutations were revealed among all patients raising the diagnostic rate to 10%. We identified a large novel GCK deletion (c.209-?_1398+?del) by MLPA in one patient and a previously reported missense substitution (c.92G > A) in HNF1A gene. CONCLUSION: This is the first investigation to perform the molecular diagnosis of MODY suspected patients. Our findings constitute a primary contribution towards unraveling the genetic landscape involved in the pathogenesis of MODY disease in Morocco.